Israel’s Kamada (reported here previously) has completed manufacturing the first batch of its plasma-derived Immunoglobulin G (IgG) product for Covid-19 patients. Initial vials of the antibody have been made available for compassionate use in Israel.

https://www.calcalistech.com/ctech/articles/0,7340,L-3834010,00.html